INTERFERON-ALPHA THERAPY FOR METASTATIC RENAL-CELL CARCINOMA

被引：0

作者：

GROSS, AJ ^{[1
]}

DIECKMANN, KP ^{[1
]}

KRAIN, J ^{[1
]}

HULAND, H ^{[1
]}

机构：

[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,UROL KLIN,W-1000 BERLIN,GERMANY

来源：

UROLOGE-AUSGABE A | 1995年 / 34卷 / 02期

关键词：

METASTATIC RENAL CELL CARCINOMA; INTERFERON ALPHA;

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Thirty-two patients with metastatic renal cell carcinoma were treated as outpatients with individually dosed interferon alpha (IFN alpha). The individual maximum dose was based on the side effects. In 7 patients the course of the disease was influenced: 1 attained complete remission, 3 patients, partial remission and 3, stable disease, The outcome of therapy was not dose-dependent, Patients with lung metastases were more sensitive to IFN alpha than the others. Up to 20 % of patients responded to the therapy.

引用

页码：158 / 161

页数：4

共 50 条

[21] INVESTIGATIONAL THERAPY OF RENAL-CELL CARCINOMA WITH RECOMBINANT ALPHA-INTERFERON
QUESADA, JR
GUTTERMAN, JU
RIOS, A
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 195 - 195
[22] INTERLEUKIN-2 AND INTERFERON-ALPHA-2A OUTPATIENT THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
LIPTON, A
HARVEY, H
GIVANT, E
HOPPER, K
LAWLER, J
MATTHEWS, Y
HIRSH, M
ZEFFREN, J
JOURNAL OF IMMUNOTHERAPY, 1993, 13 (02) : 122 - 129
[23] HISTOLOGIC CHARACTERISTICS OF RESECTED RESIDUAL RENAL-CELL CARCINOMA FOLLOWING INTERFERON-ALPHA (IFN-A)-COMBINATION THERAPY
SHIN, H
RO, J
AMIN, M
SELLA, A
AYALA, A
LABORATORY INVESTIGATION, 1993, 68 (01) : A69 - A69
[24] ASSESSING INTERFERON-ALPHA MONOTHERAPY IN PATIENTS WITH ADVANCE OR METASTATIC RENAL CELL CARCINOMA
Rai, M. K.
Nair, S. R.
McEwan, P.
VALUE IN HEALTH, 2010, 13 (07) : A252 - A252
[25] RECOMBINANT INTERFERON GAMMA IN METASTATIC RENAL-CELL CARCINOMA
DOBERAUER, C
LEBER, H
SCHOMACHER, H
AKTUELLE UROLOGIE, 1991, 22 (01) : 26 - 29
[26] Bevacizumab and interferon-α in metastatic renal-cell carcinoma
Bukowski, Ronald M.
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 253 - 254
[27] Bevacizumab and interferon-α in metastatic renal-cell carcinoma
Ronald M. Bukowski
Nature Reviews Clinical Oncology, 2009, 6 : 253 - 254
[28] INTERFERON THERAPY IN DISSEMINATED RENAL-CELL CARCINOMA
EDSMYR, F
ESPOSTI, PL
ANDERSSON, L
STEINECK, G
LAGERGREN, C
STRANDER, H
RADIOTHERAPY AND ONCOLOGY, 1985, 4 (01) : 21 - 26
[29] Subacute cutaneous lupus erythematosus after immunotherapy for renal-cell carcinoma: the case for interferon-alpha
Lee, H. Y.
Pang, S. M.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (05) : 491 - 492
[30] CYTOKINE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
OTTO, T
GOEPEL, M
LUBOLDT, HJ
RUBBEN, H
UROLOGE-AUSGABE A, 1995, 34 (03): : 200 - 203

← 1 2 3 4 5 →